Abuse-resistant controlled-release opioid dosage form
AssigneeEndo Pharmaceuticals Inc.
InventorsFrank S. Caruso, Huai-Hung Kao
Life of this patent
Estimating the term…
Loading patent…
AssigneeEndo Pharmaceuticals Inc.
InventorsFrank S. Caruso, Huai-Hung Kao
Estimating the term…
Abuse-resistant, controlled release opioid tablets are a combination containing an opioid antagonist such as naloxone at a level above that needed to suppress the euphoric effect of the opioid, if the combination were crushed to break the controlled release properties causing the opioid and opioid antagonist to be released as an immediate release product as a single dose. The controlled release nature of the tablet prevents the accumulation of orally effective amounts of opioid antagonist when taken normally. The opioid antagonist is contained in a controlled-release matrix and released, over time, with the opioid.
A method of treating a patient with an opioid agonist comprising:
Dependencies are inferred from the claim text.